Evidence map›Paper›PMID 36444635›Full record

ArticleImmunity, inflammation and disease2022

Circ_0138960 contributes to lipopolysaccharide-induced periodontal ligament cell dysfunction.

Shuangshuang Li, Huilin Xu, Yuanyuan Li, Ruijing Li

Abstract read
In one paragraph

Article in Immunity, inflammation and disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Shuangshuang LiDepartment of Stomatology, Dongying Shengli Oilfield Central Hospital, Dongying City, Shandong Province, China.
Huilin XuDepartment of Stomatology, Dongying Shengli Oilfield Central Hospital, Dongying City, Shandong Province, China.ORCID 0000-0002-1087-0240
Yuanyuan LiDepartment of Stomatology, Dongying Shengli Oilfield Central Hospital, Dongying City, Shandong Province, China.
Ruijing LiDepartment of Stomatology, Dongying Shengli Oilfield Central Hospital, Dongying City, Shandong Province, China.ORCID 0000-0002-0665-3120

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPeriodontitis is a common oral inflammatory disease, and lipopolysaccharide (LPS) is a key risk factor in periodontitis pathology. Here, we used LPS-induced periodontal ligament cells (PDLCs) to explore the molecular mechanism of periodontitis.

methodsCell viability, proliferation, and apoptosis were analyzed by Cell Counting Kit-8, 5-ethynyl-20-deoxyuridine (EDU), and flow cytometry assays, respectively. Apart from that, their targeting relationship was validated using dual-luciferase reporter and RNA-pull down.

resultsCircular RNA_0138960 (circ_0138960) was notably upregulated in periodontitis sufferers (p < .001) and LPS-disposed PDLCs (p < .05). LPS exposure dampened PDLC proliferation, and promoted apoptosis and inflammation (p < .05). Circ_0138960 acted as a microRNA sponge for miR-518a-5p to affect histone deacetylase 6 (HDAC6) expression. Circ_0138960 absence-mediated protective effects in LPS-induced PDLCs were largely abrogated via silencing miR-518a-5p or HDAC6 overexpression (p < .05).

conclusionCirc_0138960 promoted LPS-induced dysfunction in PDLCs by targeting miR-518a-5p/HDAC6 axis, which provided novel potential therapeutic targets for periodontitis.

Indexed as

MicroRNAsPeriodontal LigamentCell SurvivalHumansInflammationLipopolysaccharidesLipopolysaccharidesMicroRNAscirc_0138960HDAC6lipopolysaccharidemiR-518a-5pperiodontal ligament cellsperiodontitis

Identifiers

PMID36444635
PMCPMC9639461

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.